ГОСТ Р ИСО 10993-7— 2009
Библиография
[1]ISO 11135:1994, Medical devices — Validation and routine control of ethylene oxide sterilization
[2]EN 550:1994. Sterilization of medical devices — Validation and routine control of ethylene oxide sterilization
[3]AAMI EO-VRSU 3181; superseded by AAMI GVR-1987. Good hospital practice: Ethylene oxide gas — Ventilation
recommendations and safe use. Arlington. VA: AAMI. 1981
[4]ADLER. N. Residual ethylene oxide and ethylene glycol in ethylene oxide sterilized pharmaceuticals. J. Pharm.
Sci. 54(5) 1965: pp. 735 — 742
[5JALLEVA, F. (Cited in Balazs. 1976)
[6]AMBROSE. A. Toxicological studies of compounds investigated for use as inhibitors of biological processes.
II Toxicity of ethylene chJorohydrin. Arch. Ind. Hyg. Occup. Med. 2 1950; pp. 582 — 597.
[7]ANDERSEN. S. Ethylene oxide toxicity. J. Lab. СЛп. Med. 77(2) 1971; pp. 346 — 356.
[8]ANSI/AAM I ST29 — 1988. Recommended practice for determining residual ethylene oxide in medical devices.
Arlington. VA;AAMI, 1988.
[9]ANSI/AAM I ST30 — 1989. Determining residual ethylene chlorohydrin and ethylene glycol in medical devices.
Arlington. VA: AAMI. 1989
[10]ASTM E691:1979. Standard practice for conducting an in terlabora tory comparison study to determine the pre
cision of test methods. Philadelphia. PA: ASTM. 1979
[11]BALAZS. T. Toxicity of ethylene oxide and chloroethanol. FDA By-lines No. 3. 1976; pp. 150 — 155
[12] BALL. N .A. Determination of ethylene chlorohydrin and ethylene glycol in aqueous solutions and ethylene oxide
in associated plastics. J. Pharm. Sd. 73(9) 1984; pp. 1305 — 1307
[13]BLOOD. F. Chronic toxicity of ethylene glycol in the rat. Fd. Cosmet. Tox. 3 1965; pp. 229 — 234
[14] BROBST. K.M. and HAN, T. Determination of chlorohydrins in hydroxypropyl starch ethers. J. Assoc. Off. Anal.
Chem. 54(5) 1971; pp. 1093 — 1094
[15] BROWN. D.J. Determination of ethylene oxide and ethylene chlorohydrin in plastic and rubber surgical equipment
sterilized with ethylene oxide. J. Assoc. Off. Anal. Chem. 53(2) 1970: pp. 263 — 267
[16] BRUCH. C.W. industrial Sterilization. Phillips. G.B., Miller. W.S. (Eds.) Durham. NC: Duke University Press. 1973;
pp.
49
_
77
[17] CARPENTER. C.. SMMH. H. and POZZANI. U. The assay of acute vaportoxicity, and the grading and interpretation
of results on 96 chemical compounds. J. Ind. Hyg. Toxicol. 31 1949: pp. 343 — 349 (Cited in EPA. 1985)
[18]CHESLER. S.N., REBBERT. R.E. and ENAGONIO. D. P. Evaluation ofAA Ml EO residues recommended practice
and a determination of EO kinetics in water Washington. DC: National Bureau of Standards, Department of
Commerce, Oct. 1985.
[19]CONINE. D.. NAUMANN. B. and HECKER. L. Setting health-based residue limits for contaminants in pharma
ceuticals and medical devices. Quality Assurance: Good Practice. Regulation, and Law. 1 1992; pp. 171 — 180
[20]COURTNEY. K.. ANDREWS. J. and GRADY. M. Teratogenic evaluation of ethylene chlorohydrins (Ech.
2-chloroethanol) in mice. J. Environ. Sci. Health. BI7(4) 1982; pp. 381 — 391
[21]CYR. W.H.. GLASER, Z.R. and JACOBS. M.E. CDRH risk assessment of EO residues on sterilized medical devices In:
Jorkasky, J. (Ed.) Sterilization in the 1990s (Health Industry Manufacturers’Association Report No. HIMA 89-I).
Washington. DC: HIMA. 1989: pp. 269 — 285
[22] DANIELSON. J.W., SNELL. R.P. and OXBORROW. G.S. Detection and quantitation of ethylene oxide.
2-chloroethanol. and ethylene glycol with capillary gas chromatography. J. Chromatogr. 28 1990: pp. 97 — 101
[23] DEPASS. L.. GARMAN, R.. WOODSIDE. M.. GIDDENS. W.. MARONPOT. R. and WEIL. C. Chronic toxicity and
carcinogenicity studies of ethylene glycol in rats and mice. Fund. Appl. Tox. 7 1986; pp. 547 — 565
[24] DUNKELBERG. H. Carcinogenicity of ethylene oxide and 1.2-propylene oxide upon intragastric administration to
rats. Br. J. Cancer. 46 1982; pp. 924 — 933
[25] EDELHAUSER. H.. ANTOINE. M.. PEDERSON. H.. HIDDEMAN. J. and HARRIS. R. Intraocular safety evaluation of
ethylene oxide and sterilant residues. J. Toxicol. Cut. and Ocular Toxicol. 2 1983: pp. 7 — 39
[26] Environ. Ethylene Oxide Residues on Sterilized Medical Devices. Washington. DC. Environ Corporation. 1987.
(Also in: Health Industry Manufacturers Association. H/MA Report 88-6. Washington. DC: HIMA. 1988)
[27] ETTRE. L.S. and JONES. E. Quantitative analysis with headspace gas chromatography using multiple headspace
extraction. Chromatography Newsletter. 12( 1) July 1984
[28]GAUNT. J.. HARDY. J.. GANGOLLI. S.. BUTTERWORTH. K. and LLOYD. A. B/BRA. 14 1975: p. 109. (Cited in Rowe
and Wolf. 1982 and Environ. 1987)
[29]GLASER. Z.R. Ethylene oxide: Toxicology review and field study results of hospital use. 4. Environ. Path.
Tox. 2 1979; pp. 173 — 208
[30]GOLBERG. L. Hazard Assessment of Ethylene Oxide. Boca Raton. FL: CRC Press. 1986
[31]GUESS. W. Tissue reactions to 2-chloroethanol in rabbits. Tox. Appl. Pharm. 16 1970: pp. 382 — 390
[32] Guidelines for data acquisition and data quality evaluation in environmental chemistry. Anal. Chem. 52(14) 1980.
[33] HACKETT. P.. BROWN. R„ BUSCHBOOM. R.. CLARK. M.. MILLER. R.. MUSIC. R.. ROWE. S„ SCHIRMER. R. and
SIKOV. M. Teratogenic Study of Ethylene Oxide and Propylene Oxide and n-Butyl Acetate (NIOSH Contract No. 21
0-80-001 3). Richland. WA: Battelle Pacific Northwest Laboratories. 1982. (Cited in EPA. 1985.)
35